Mathews Journal of Pharmaceutical Science

2474-753X

Previous Issues Volume 8, Issue 4 - 2024

Cyclotron Technology: Revolutionizing Nuclear Medicine for Geriatric Disorders

Mohammad Nadeem khan*

Department of Pharmacology (Clinical Pharmacology), Sri Aurobindo Medical College &PG Institute, Sri Aurobindo University, Indore, Madhya Pradesh, India

*Corresponding author: Mohammad Nadeem khan, Department of Pharmacology (Clinical Pharmacology), Sri Aurobindo Medical College &PG Institute, Sri Aurobindo University, Indore, Madhya Pradesh, India, Tel:  9303362451, E-mail: [email protected]

Received Date: November 22, 2024

Published Date: December 14, 2024

Citation: Khan MN. (2024). Cyclotron Technology: Revolutionizing Nuclear Medicine for Geriatric Disorders. Mathews J Pharma Sci. 8(4):43.

Copyrights: Khan MN. © (2024).

ABSTRACT

Cyclotron technology has become a transformative tool in nuclear medicine, addressing the increasing burden of geriatric disorders, including neurodegenerative diseases and cancer. This article explores the applications of cyclotron-generated isotopes in diagnosis and therapy, with a focus on advancements in tracer techniques, theranostics, and their benefits in geriatric healthcare. Additionally, it highlights current challenges, proposes prospective solutions, and outlines research directions to further enhance the role of cyclotron technology in managing age-related disorders.

Keywords: Geriatric Disorders, Radiopharmaceuticals, Alzheimer’s Disease, Parkinson’s Disease, Theranostics, Advanced Imaging, Targeted Therapy, Isotope Production, Fluorine-18, Lutetium-177, Healthcare Innovation.


Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com